Mathematical and Statistical Modeling for Emerging and Re-Emerging Infectious Diseases 2016
DOI: 10.1007/978-3-319-40413-4_14
|View full text |Cite
|
Sign up to set email alerts
|

Optimal Control of Vaccination in an Age-Structured Cholera Model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 45 publications
0
9
0
Order By: Relevance
“…For example, the US Centers for Disease Control and Prevention (CDC) used real-time modeling to predict the effects of vaccination during the 2010 cholera epidemic in Haiti and to anticipate the total numbers of cases and hospitalizations [25]. More broadly, a wide range of cholera transmission models have been developed [2631], accounting for different mechanisms, including spatial dynamics [29, 32, 33], age structure [34, 35], environmental drivers [3639], and disease transmission characteristics such as proportion of asymptomatic individuals [38], hyperinfectiousness [40], dose response effects [27, 29, 41, 42], and multiple transmission pathways [28, 30]. One particularly relevant modeling analysis examined the impact of one compared with two doses of cholera vaccine in Haiti, Zimbabwe, and Guinea when supplies are limited [43].…”
Section: Introductionmentioning
confidence: 99%
“…For example, the US Centers for Disease Control and Prevention (CDC) used real-time modeling to predict the effects of vaccination during the 2010 cholera epidemic in Haiti and to anticipate the total numbers of cases and hospitalizations [25]. More broadly, a wide range of cholera transmission models have been developed [2631], accounting for different mechanisms, including spatial dynamics [29, 32, 33], age structure [34, 35], environmental drivers [3639], and disease transmission characteristics such as proportion of asymptomatic individuals [38], hyperinfectiousness [40], dose response effects [27, 29, 41, 42], and multiple transmission pathways [28, 30]. One particularly relevant modeling analysis examined the impact of one compared with two doses of cholera vaccine in Haiti, Zimbabwe, and Guinea when supplies are limited [43].…”
Section: Introductionmentioning
confidence: 99%
“…This value is in line with data concerning the 2009 H1N1 influenza pandemic, whose daily rate of vaccination has been largely investigated, and it was below 2% of the total population (see Lee et al, 2012 and references therein). Furthermore, threshold values of 1–2% per day were also considered in epidemic models of dengue Shim, 2019 and cholera diseases Fister et al, 2016 .…”
Section: Parametrisationmentioning
confidence: 99%
“…This value is in line with data concerning the 2009 H1N1 pandemic inuenza, whose daily rate of vaccine administration has been largely investigated and it was below 2% of the total population (see [49] and references therein). Furthermore, threshold values of 12% per day were also considered in epidemic models of dengue [67] and cholera diseases [30].…”
Section: Baseline Scenariomentioning
confidence: 99%